Overview

A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma

Status:
Terminated
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
Determine the objective response rate in sarcoma patients treated with hydroxychloroquine and sirolimus.
Phase:
Phase 2
Details
Lead Sponsor:
Shin Kong Wu Ho-Su Memorial Hospital
Treatments:
Everolimus
Hydroxychloroquine
Sirolimus